48 filings
10-Q
2024 Q1
NMRA
Neumora Therapeutics Inc.
Quarterly report
7 May 24
4:01pm
8-K
NMRA
Neumora Therapeutics Inc.
7 May 24
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
7:15am
DEFA14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Additional proxy soliciting materials
4:15pm
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
8-K
NMRA
Neumora Therapeutics Inc.
15 Apr 24
Other Events
6:46am
S-8
cyv2z
7 Mar 24
Registration of securities for employees
4:34pm
10-K
9z1nenwo2i0w53v4
7 Mar 24
Annual report
4:05pm
8-K
de6gsh k4sfn92fvs
7 Mar 24
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023
7:08am
8-K
kntpu
8 Jan 24
Regulation FD Disclosure
8:32am
8-K
skq2cdqusa1v3hkk
28 Nov 23
Other Events
4:21pm
10-Q
rjhxwejcrm yvlmx
1 Nov 23
Quarterly report
4:05pm
8-K
pqjutmmfi6uhjk4cxx
1 Nov 23
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:01pm
S-8
n8dr656060csn jsqhxz
19 Sep 23
Registration of securities for employees
9:57pm
8-K
c4080k7
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
s88437ums0k
18 Sep 23
Prospectus supplement with pricing info
4:12pm
EFFECT
mhe903
18 Sep 23
Notice of effectiveness
12:15am
CERT
raaszf7 w4
14 Sep 23
Certification of approval for exchange listing
2:03pm
SEC STAFF LETTER
ks52bfz
14 Sep 23
SEC staff letter
12:00am
8-A12B
hu7uie4zqqtl 5kmm
13 Sep 23
Registration of securities on exchange
5:00pm
CORRESP
k4pndy3rki
12 Sep 23
Correspondence with SEC
12:00am